Reata pharmaceuticals market cap

Author: neol

August undefined, 2024

Webb13 apr. 2024 · Shares of RETA stock opened at $96.49 on Thursday. Reata Pharmaceuticals has a 1-year low of $18.47 and a 1-year high of $98.52. The company … WebbReata Pharmaceuticals market cap history and chart from 2015 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the …

Stifel Maintains Reata Pharmaceuticals (RETA) Buy …

WebbShares of Reata Pharmaceuticals ... Biopharma industry experts still expect Lupkynis sales to top out above $1 billion but Aurinia's market cap at the moment is just $1.4 billion. Webb30 mars 2024 · Reata Pharmaceuticals Stock Performance Shares of NASDAQ RETA opened at $90.04 on Thursday. The stock has a market cap of $3.31 billion, a PE ratio of -10.52 and a beta of 1.27. The business has a fifty day moving average of $61.94 and a two-hundred day moving average of $43.42. tela samsung s7 edge dourado

Stifel Raises Price Target on Reata Pharmaceuticals to $115 From …

Webb13 apr. 2024 · Shares of RETA stock opened at $96.49 on Thursday. Reata Pharmaceuticals has a 1-year low of $18.47 and a 1-year high of $98.52. The company has a market capitalization of $3.54 billion, a price-to-earnings ratio of -11.27 and a beta of 1.52. The stock's fifty day simple moving average is $72.33 and its 200-day simple … WebbThe main stock indexes are way down over the past year, but quite a few under-the-radar stocks have bucked the trend. Reata Pharmaceuticals (NASDAQ: RETA) was a clinical … WebbSector Industry Market Cap Revenue; Medical: Medical - Biomedical and Genetics: $3.339B: $0.002B: Reata Pharmaceuticals is a clinical-stage pharmaceutical company primarily focused on discovering, developing and commercializing small-molecule based innovative therapies for treating severe, life-threatening diseases with a few or no approved therapies. tela sargalina

Reata Pharmaceuticals, Inc. (RETA) Market Cap & Net Worth

Reata Pharmaceuticals Stock Price Today (NASDAQ: RETA) …

Webb28 feb. 2024 · Reata Pharmaceuticals SKYCLARYS™ Approval Conference Call Script ... Capital Markets Transactions. New Contracts. Profit Warnings. ... our Chief Medical Officer, will discuss, we received full approval for SKYCLARYS in FA, and we have finalized our post-marketing commitments and are preparing to meet those commitments ... WebbAccording to Reata Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $2.21 M . In 2024 the company made a revenue of $11.48 M an … tela sarga 100 algodonWebb7 apr. 2024 · Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious … tela sarga blanca

"Webb14 apr. 2024 · RETA opened at $96.01 on Thursday. Reata Pharmaceuticals has a 52 week low of $18.47 and a 52 week high of $98.89. The firm has a market capitalization of $3.53 billion, a PE ratio of -11.22 and a ... " - Reata pharmaceuticals market cap

Reata pharmaceuticals market cap

WebbReata Pharmaceuticals, Inc. (RETA) Stock Price, News, Quote & History - Yahoo Finance U.S. markets closed Dow 30 Nasdaq -52.48(-0.43%) Russell 2000 +14.15(+0.80%) Crude Oil +1.73(+2.17%) Reata... Discover historical prices for RETA stock on Yahoo Finance. View daily, weekly or … Find the latest Reata Pharmaceuticals, Inc. (RETA) stock discussion in Yahoo … Find out all the key statistics for Reata Pharmaceuticals, Inc. (RETA), including … Holder Shares Date Reported % Out Value; Vanguard Specialized-Health Care Fund: … The latest news and headlines from Yahoo! News. Get breaking news stories and in … See Reata Pharmaceuticals, Inc. (RETA) stock analyst estimates, including … Find the latest Reata Pharmaceuticals, Inc. (RETA) stock quote, history, news and … See the company profile for Reata Pharmaceuticals, Inc. (RETA) including … WebbReata Pharmaceuticals, Inc.'s stock is down 14%, but insiders still have about US$163k in profit after buying earlier this year. Simply Wall St. Nov-10-22 04:42PM. Reata Pharmaceuticals Announces Participation in the Guggenheim 2024 Immunology and Neurology Conference and the Stifel 2024 Healthcare Conference.

Did you know?

WebbView the latest Reata Pharmaceuticals Inc. Cl A (RETA) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebbAs of February 2024, Reata Pharmaceuticals (RETA) has a market cap of $1.8 billion. Our data points out that RETA is ranked #3890 in the world. A company's market …

Webb6 apr. 2024 · As of April 6, 2024, the average one-year price target for Reata Pharmaceuticals is $115.97. The forecasts range from a low of $75.75 to a high of … Webb28 feb. 2024 · Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a biopharmaceutical company focused on developing and commercializing novel therapies for patients with severe diseases, announced that the U.S. Food and Drug Administration (“FDA”) has approved SKYCLARYS™ (omaveloxolone) for the treatment …

WebbBuy Reata Pharmaceuticals Inc stock & View ($RETA) Share Price on eToro. Reata Pharmaceuticals Inc Performance 0% Past Week Market Cap 3.48B Day’s Range 89.91 - 93.95 52W Range 18.44 - 96.60 Volume (3M) 1.5M Price-Earnings Ratio -11 Revenue 2.22M Reata Pharmaceuticals Inc Latest News View All WebbLearn to value Reata Pharmaceuticals, Inc. (RETA) stock with easy-to-understand analysis. ... Here we also display the market cap and forecasted growth for additional consideration. Company PB Estimated Growth Market Cap; Peer Average: 3.1x: PBH Prestige Consumer Healthcare. 1.9x: 5.1%:

WebbAt Reata Pharmaceuticals, our mission is to develop innovative therapies that change patients’ lives for the better. Our Pipeline Reata’s development programs have created a …

Webb6 apr. 2024 · As of April 6, 2024, the average one-year price target for Reata Pharmaceuticals is $115.97. The forecasts range from a low of $75.75 to a high of $207.90. The average price target represents an ... tela sarga negraWebb11 apr. 2024 · Before placing your own bet on Reata, you should know that expectations are already so high that the company sports a huge $3.5 billion market cap at the … tela sarga goldenWebbFör 1 dag sedan · REATA PHARMACEUTICALS, INC. : Financial analyst guidance for REATA PHARMACEUTICALS, INC. Stock Nasdaq: RETA Nasdaq tela sarga algodonWebb30 mars 2024 · Reata Pharmaceuticals Stock Price Today (NASDAQ: RETA) Quote, Market Cap, Chart WallStreetZen Reata Pharmaceuticals Inc Stock Add to Watchlist Overview … telasaroWebb29 mars 2024 · REATA PHARMACEUTICALS, INC. : Trading strategies, financial analysis, commentaries and investment guidance for REATA PHARMACEUTICALS, INC. Stock Nasdaq: RETA Nasdaq. Advanced search ... All new media materials are captured as the controversy progresses. The controversies score also addresses the market cap bias … tela saten negroWebb23 okt. 2004 · Shares of Reata Pharmaceuticals ... Another positive result could quickly cause this company's modest $588 million market cap to double again. 10 stocks we like better than Reata Pharmaceuticals tela sarga sublimadaWebb10 apr. 2024 · Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or … telasat